Risk for Disability Worsening Increased for MS With Comorbid Depression
The risk for disability worsening is increased for individuals with multiple sclerosis (MS) and comorbid depression, according to a study published in Neurology.
The risk for disability worsening is increased for individuals with multiple sclerosis (MS) and comorbid depression, according to a study published in Neurology.
In a revised 2019 guideline, updated recommendations from the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) are presented for the diagnosis and treatment of multiple sclerosis (MS).
Multiple sclerosis seems to prevent individuals from realizing their full potential at home and work, with fatigue being overwhelmingly identified as the cause, according to preliminary findings presented at ECTRIMS 2019.
Limited data are available regarding the satisfaction of patients with MS with their first diagnostic consultation (FDC). The goal of the current retrospective study was to identify FDC factors that may influence patient satisfaction.
AAN has issued a practice guideline update for vaccine-preventable infections and immunizations for individuals with multiple sclerosis (MS). A subcommittee of the AAN — tasked with developing, disseminating and implementing these guidelines — found improvements and additions to the recommendations previously issued in 2002.
Review of Medicare claims from 2006 to 2016 show 10.2-fold and 7.2-fold hikes in pharmaceutical and out-of-pocket spending, respectively.
Having a higher burden of comorbidities is associated with greater disability progression and lower QoL, as well as increased healthcare utilization and mortality.